Natco Pharma under its brand Hepcinat Plus has launched the generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg Tablet, for the treatment of patients with chronic hepatitis C virus (HCV) infection. The company has launched Hepcinat Plus at Rs 17,500, for a bottle of 28 tablets.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
